Anti-HAAH vaccine
IND- Indications
- Liver cancer, Breast cancer, Prostate cancer
Company intelligence / Profile preview
Panacea Pharmaceuticals, Inc.
Maryland, United Statespanaceapharmagroup.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
As of 2016, the company was planning to initiate Phase 1 clinical study of its lead cancer immunotherapeutic drug candidate, a nanoparticle-based anti-cancer therapeutic vaccine[8]
- Therapeutic areas
- Oncology
- Modalities
- Nanoparticle-based vaccinesantibodiessmall moleculesradioimmunodiagnosticsradioimmunotherepeutics
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Panacea Pharmaceuticals, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Panacea Pharmaceuticals, Inc..